ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.720,01
-1,47%
S&P 500
5.702,55
-0,19%
Dow Jones
42.063,36
0,09%
Euro vs US Dollar
1,11705
0,00%
Bitcoin
62.960,68
-0,66%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Adicet Bio Inc (ACET)

  7. Adicet Bio Inc (ACET) News

ACET

Adicet Bio (ACET)

Adicet Bio Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ACET
DatumZeitQuelleÜberschriftSymbolFirma
19/09/202413h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
19/09/202413h00Business WireADI-001 Clinical Biomarker Data Demonstrate Robust Tissue Trafficking and Complete B Cell Depletion in Secondary Lymphoid TissueNASDAQ:ACETAdicet Bio Inc
10/09/202413h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
30/08/202423h44Business WireAdicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
27/08/202422h00Business WireAdicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ACETAdicet Bio Inc
23/08/202422h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
23/08/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
23/08/202422h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
20/08/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
20/08/202422h03Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
19/08/202422h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
19/08/202413h00Business WireAdicet Bio Appoints Lloyd Klickstein, M.D., Ph.D. to the Board of DirectorsNASDAQ:ACETAdicet Bio Inc
13/08/202413h04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACETAdicet Bio Inc
13/08/202413h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
13/08/202413h00Business WireAdicet Reports Second Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:ACETAdicet Bio Inc
01/08/202422h00Business WireAdicet Bio to Participate in Upcoming Investor ConferencesNASDAQ:ACETAdicet Bio Inc
31/07/202423h25Business WireAdicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
08/07/202413h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
08/07/202413h00Business WireAdicet Bio Receives FDA Fast Track Designation for ADI-270 in Metastatic/Advanced Clear Cell Renal Cell CarcinomaNASDAQ:ACETAdicet Bio Inc
28/06/202423h00Business WireAdicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
24/06/202413h00Business WireAdicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell CarcinomaNASDAQ:ACETAdicet Bio Inc
07/06/202422h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
07/06/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
07/06/202422h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
07/06/202422h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
07/06/202422h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
07/06/202422h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
05/06/202413h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
05/06/202413h00Business WireAdicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus NephritisNASDAQ:ACETAdicet Bio Inc
31/05/202423h41Business WireAdicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
 Showing the most relevant articles for your search:NASDAQ:ACET

Kürzlich von Ihnen besucht

TG
D7G
Nel ASA
NASDAQ
TSLA
Tesla
TG
TUI1
Tui
CCOM
US500
US 500
USOTC
ADDYY
Adidas (QX)
NYSE
DIS
Walt Disney
CCOM
US30
US 30
NYSE
XOM
Exxon Mobil
TG
CBK
Commerzbank
FX
EURGBP
Euro vs Sterling
TG
DTE
Deutsche Telekom
TG
DBK
Deutsche Bank
NYSE
KO
Coca Cola
COIN
XRPUSD
Ripple
AMEX
XLE
Energy Select Sector SPDR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten